Company · CIK 1760854

# Nanobiotix S.A.

| CIK | [1760854](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001760854) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | I0 |
| Business address | France |
| Listed | NBTX (Nasdaq), NNBXF (OTC) |
| First annual or quarterly report | 2021-04-07 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-285604 | Shelf Effective | 2025-03-06 | 2026-05-22 | 4 |
| 333-262545 | Shelf Effective | 2022-02-04 | 2023-11-06 | 4 |
| 333-250707 | IPO Final prospectus | 2020-11-20 | 2020-12-11 | 5 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1760854/000114036126022604/0001140361-26-022604-index.htm) Shelf takedown | 333-285604 | 0001140361-26-022604 |
| 2026-05-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1760854/000114036126022247/0001140361-26-022247-index.htm) Shelf takedown | 333-285604 | 0001140361-26-022247 |
| 2025-03-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1760854/999999999525000694/9999999995-25-000694-index.htm) Declared effective | 333-285604 | 9999999995-25-000694 |
| 2025-03-06 | [F-3](https://www.sec.gov/Archives/edgar/data/1760854/000114036125007433/0001140361-25-007433-index.htm) Shelf registered | 333-285604 | 0001140361-25-007433 |
| 2023-11-06 | [424B5](https://www.sec.gov/Archives/edgar/data/1760854/000114036123051573/0001140361-23-051573-index.htm) Shelf takedown | 333-262545 | 0001140361-23-051573 |
| 2023-11-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1760854/000114036123050907/0001140361-23-050907-index.htm) Shelf takedown | 333-262545 | 0001140361-23-050907 |
| 2022-02-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1760854/999999999522000476/9999999995-22-000476-index.htm) Declared effective | 333-262545 | 9999999995-22-000476 |
| 2022-02-04 | [F-3](https://www.sec.gov/Archives/edgar/data/1760854/000114036122003928/0001140361-22-003928-index.htm) Shelf registered | 333-262545 | 0001140361-22-003928 |
| 2020-12-11 | [424B4](https://www.sec.gov/Archives/edgar/data/1760854/000114036120028188/0001140361-20-028188-index.htm) Final prospectus | 333-250707 | 0001140361-20-028188 |
| 2020-12-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1760854/999999999520003484/9999999995-20-003484-index.htm) Declared effective | 333-250880 | 9999999995-20-003484 |
| 2020-12-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1760854/999999999520003482/9999999995-20-003482-index.htm) Declared effective | 333-250707 | 9999999995-20-003482 |
| 2020-12-09 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1760854/000114036120027910/0001140361-20-027910-index.htm) Amendment | 333-250707 | 0001140361-20-027910 |
| 2020-12-07 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1760854/000114036120027413/0001140361-20-027413-index.htm) Amendment | 333-250707 | 0001140361-20-027413 |
| 2020-11-20 | [F-1](https://www.sec.gov/Archives/edgar/data/1760854/000114036120026217/0001140361-20-026217-index.htm) Registration filed | 333-250707 | 0001140361-20-026217 |
| 2018-12-21 | [DRS](https://www.sec.gov/Archives/edgar/data/1760854/000114036118045590/0001140361-18-045590-index.htm) Draft made public | 377-02433 | 0001140361-18-045590 |

[All filings of this company](https://equitycapital.markets/filings?cik=1760854) · [CSV](https://equitycapital.markets/filings.csv?cik=1760854)

---
Source page: https://equitycapital.markets/company/1760854 · Data: U.S. SEC EDGAR · CC BY 4.0